English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 
Helsinn Group announces the launch of the IV formulation of AKYNZEO(R) (fosnetupitant/palonosetron) in the United States
May 09, 2018 09:00 HKT
Nanobiotix partners with Weill Cornell Medicine on pre-clinical studies to evaluate the impact of NBTXR3 on cGAS-STING pathway in mammary cancers
May 04, 2018 09:00 HKT
Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Apr 20, 2018 22:10 HKT
LEH PHARMA LTD.: Company Update
Apr 18, 2018 20:30 HKT
Tusk Therapeutics presents data on to its anti-CD25 programme at AACR Annual Meeting 2018
Apr 18, 2018 20:00 HKT
AACR annual meeting 2018: Nanobiotix presented preclinical data showing NBTXR3 nanoparticles can activate the cGAS-STING pathway
Apr 18, 2018 09:00 HKT
Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy
Apr 17, 2018 08:00 HKT
The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab
Apr 11, 2018 09:00 HKT
Nanobiotix 2017 Annual Results
Mar 30, 2018 22:10 HKT
Helsinn Healthcare S.A.: Winners of the inaugural Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced
Mar 28, 2018 21:50 HKT
Tusk Therapeutics to Present Data at AACR Annual Meeting 2018
Mar 28, 2018 14:00 HKT
Printing the 'Soft' Robots of the Future
Mar 12, 2018 14:30 HKT
ETRI's Cup Holder Charges Phones Wirelessly
Mar 07, 2018 07:30 HKT
Tracking Ocean Salinity from Space using Colour
Feb 19, 2018 23:00 HKT
Rolling in it: Dung Beetles' Taste Preferences Uncovered
Feb 09, 2018 20:00 HKT
Ultra-high speed Wi-Fi developed for Seoul's subway trains
Feb 08, 2018 19:00 HKT
Sanofi Delivers 2017 Business EPS in line with Guidance
Feb 07, 2018 15:00 HKT
Moving beyond graphene
Feb 01, 2018 19:30 HKT
Aldebaran5, Next Generation Autonomous Vehicle Computing Platform in a Single Chip
Jan 26, 2018 20:30 HKT
Nanobiotix Presents First Promising Data from Phase I/II Liver Cancers Trial of NBTXR3 at the American Society of Clinical Oncology Gastrointestinal Annual Meeting
Jan 22, 2018 15:00 HKT
Next >>
Copyright © 2018 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: